346 related articles for article (PubMed ID: 34545625)
1. Are the chilblain-like lesions observed during the COVID-19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta-analysis.
Sánchez-García V; Hernández-Quiles R; de-Miguel-Balsa E; Docampo-Simón A; Belinchón-Romero I; Ramos-Rincón JM
J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):24-38. PubMed ID: 34545625
[TBL] [Abstract][Full Text] [Related]
2. Chilblain-Like Lesions (CLL) Coinciding With the SARS-CoV-2 Pandemic in Children: A Systematic Review.
Starkey SY; Kashetsky N; Lam JM; Dutz J; Mukovozov IM
J Cutan Med Surg; 2023; 27(3):277-284. PubMed ID: 37340564
[TBL] [Abstract][Full Text] [Related]
3. Chilblain-Like Lesions (CLL) Associated With COVID-19 ("COVID Toes"): A Systematic Review.
Kashetsky N; Mukovozov IM; Bergman J
J Cutan Med Surg; 2021; 25(6):627-633. PubMed ID: 33849305
[TBL] [Abstract][Full Text] [Related]
4. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing.
Le Cleach L; Dousset L; Assier H; Fourati S; Barbarot S; Boulard C; Bourseau Quetier C; Cambon L; Cazanave C; Colin A; Kostrzewa E; Lesort C; Levy Roy A; Lombart F; Marco-Bonnet J; Monfort JB; Samimi M; Tardieu M; Wolkenstein P; Sbidian E; Beylot-Barry M;
Br J Dermatol; 2020 Nov; 183(5):866-874. PubMed ID: 32628270
[TBL] [Abstract][Full Text] [Related]
5. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
El Hachem M; Diociaiuti A; Concato C; Carsetti R; Carnevale C; Ciofi Degli Atti M; Giovannelli L; Latella E; Porzio O; Rossi S; Stracuzzi A; Zaffina S; Onetti Muda A; Zambruno G; Alaggio R
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2620-2629. PubMed ID: 32474947
[TBL] [Abstract][Full Text] [Related]
6. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.
Hubiche T; Cardot-Leccia N; Le Duff F; Seitz-Polski B; Giordana P; Chiaverini C; Giordanengo V; Gonfrier G; Raimondi V; Bausset O; Adjtoutah Z; Garnier M; Burel-Vandenbos F; Dadone-Montaudié B; Fassbender V; Palladini A; Courjon J; Mondain V; Contenti J; Dellamonica J; Leftheriotis G; Passeron T
JAMA Dermatol; 2021 Feb; 157(2):202-206. PubMed ID: 33237291
[TBL] [Abstract][Full Text] [Related]
7. Chilblain or perniosis-like skin lesions in children during the COVID-19 pandemic: A systematic review of articles.
Molaee H; Emadi SN; M Imunya JMN; Davoudi-Monfared E; Mohammed A; Razavi Z
Dermatol Ther; 2022 Mar; 35(3):e15298. PubMed ID: 34981615
[TBL] [Abstract][Full Text] [Related]
8. Chilblain-like lesions coinciding with the SARS-CoV-2 pandemic.
Starkey SY; Mar K; Kashetsky N; Lam JM; Dutz J; Mukovozov I
Clin Dermatol; 2023; 41(1):223-229. PubMed ID: 36228990
[TBL] [Abstract][Full Text] [Related]
9. No SARS-CoV-2 antibody response in 25 patients with pseudo-chilblains.
Docampo-Simón A; Sánchez-Pujol MJ; Gimeno-Gascon A; Palazón-Cabanes JC; Juan-Carpena G; Vergara-De Caso E; González-Villanueva I; Blanes-Martínez M; Betlloch-Mas I
Dermatol Ther; 2020 Nov; 33(6):e14332. PubMed ID: 32975345
[TBL] [Abstract][Full Text] [Related]
10. Thoracic imaging tests for the diagnosis of COVID-19.
Salameh JP; Leeflang MM; Hooft L; Islam N; McGrath TA; van der Pol CB; Frank RA; Prager R; Hare SS; Dennie C; Spijker R; Deeks JJ; Dinnes J; Jenniskens K; Korevaar DA; Cohen JF; Van den Bruel A; Takwoingi Y; van de Wijgert J; Damen JA; Wang J; ; McInnes MD
Cochrane Database Syst Rev; 2020 Sep; 9():CD013639. PubMed ID: 32997361
[TBL] [Abstract][Full Text] [Related]
11. Major cluster of paediatric 'true' primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown.
Neri I; Virdi A; Corsini I; Guglielmo A; Lazzarotto T; Gabrielli L; Misciali C; Patrizi A; Lanari M
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2630-2635. PubMed ID: 32533899
[TBL] [Abstract][Full Text] [Related]
12. RNAscope in situ hybridization and RT-PCR for detection of SARS-CoV-2 in chilblain-like lesions: A clinical, laboratory and histopathological study.
Robustelli Test E; Sena P; Locatelli AG; Carugno A; di Mercurio M; Moggio E; Gambini DM; Arosio MEG; Callegaro A; Morotti D; Gianatti A; Vezzoli P
Pediatr Dermatol; 2022 Jan; 39(1):77-83. PubMed ID: 34989043
[TBL] [Abstract][Full Text] [Related]
13. Chilblains in children in the setting of COVID-19 pandemic.
Andina D; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I; Torrelo A
Pediatr Dermatol; 2020 May; 37(3):406-411. PubMed ID: 32386460
[TBL] [Abstract][Full Text] [Related]
14. Do we have serological evidences that chilblain-like lesions are related to SARS-CoV-2? A review of the literature.
Balestri R; Magnano M; Rizzoli L; Rech G
Dermatol Ther; 2020 Nov; 33(6):e14229. PubMed ID: 32844512
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic perniosis presenting as acral purpuric lesions: Clustering of cases before COVID-19 pandemic and their comparison with chilblain like lesions reported in the literature.
Jindal R; Chauhan P; Goyal D; Shirazi N
Dermatol Ther; 2021 May; 34(3):e14951. PubMed ID: 33740317
[TBL] [Abstract][Full Text] [Related]
16. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
[TBL] [Abstract][Full Text] [Related]
17. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L
Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236
[TBL] [Abstract][Full Text] [Related]
18. Routine laboratory testing to determine if a patient has COVID-19.
Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
[TBL] [Abstract][Full Text] [Related]
19. Physical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
[TBL] [Abstract][Full Text] [Related]
20. Going viral: A brief history of Chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemic.
Massey PR; Jones KM
Semin Oncol; 2020 Oct; 47(5):330-334. PubMed ID: 32736881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]